Subscribe
Share
Share
Embed
Ottawa doesn’t want to miss the boat on a potential Blockbuster-to-Netflix moment in the way people spend their money.
A newly approved Alzheimer’s drug promises miraculous results, but it won’t come cheap.
Ottawa doesn’t want to miss the boat on a potential Blockbuster-to-Netflix moment in the way people spend their money.
A newly approved Alzheimer’s drug promises miraculous results, but it won’t come cheap.
Fast Canadian business news. Get up-to-speed quick with a fun and smart breakdown of the three biggest Canadian and global business stories in less than 10 minutes.